LCI up +2.53% percent right now. $LCI High is at 52.05 and the Low 50.18 with current volume of 322,219.
Recent News posted below.
LCI Lannett Co Inc Recent Headline News
La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:44AM CST
La Jolla Pharmaceutical Co. (LJPC) was a big mover last session, as the company saw its shares surge over 10% on the day
ENDP: 68.87 (-0.09), LCI: 51.48 (+1.31), BCRX: 10.77 (+0.31), LJPC: 13.40 (+1.12)
Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 36.50 (-0.93), LCI: 51.48 (+1.31), AKRX: 35.28 (-1.31), AFSI: 50.43 (+0.54), EXPE: 85.89 (+0.78), FFIV: 126.83 (+0.17), SLXP: 93.62 (+2.15), MPWR: 44.85 (+0.16), TMH: 53.69 (-0.45), ATHM: 44.35 (+0.72)
Let Major Indexes Dictate Buy, Sell Decisions
at Investor's Business Daily - Wed Nov 05, 5:01PM CST
The S&P 500 and Nasdaq composite serve as guideposts to the market's health. Ignore them at your own peril. Every day, IBD analyzes the action of these major stock averages to determine whether the market is in an uptrend (healthy) or a correction...
LCI: 51.48 (+1.31), AKRX: 35.28 (-1.31), ORLY: 179.38 (+0.38), AFSI: 50.43 (+0.54), CELG: 107.62 (+1.17)
Stocks Narrow Losses; Airlines Lead
at Investor's Business Daily - Tue Nov 04, 12:29PM CST
Stocks narrowed losses near midday Tuesday, but some leaders remained under pressure. The Nasdaq fell 0.6%, the S&P 500 dropped 0.4%, and the Dow Jones industrial average was down a fraction. Wal-Mart Stores (WMT), Travelers (TRV) and Procter &...
LCI: 51.48 (+1.31), SAVE: 78.72 (+1.41), WMT: 79.79 (+1.02), PG: 89.11 (-0.02), ATHM: 44.35 (+0.72), TXRH: 31.83 (+0.04), LUV: 38.79 (+0.55), TRV: 102.87 (+0.50)
Insider Trading Alert - LGF, OMI And LCI Traded By Insiders
at The Street - Tue Nov 04, 10:35AM CST
Stocks with insider trader activity include LGF, OMI and LCI
LCI: 51.48 (+1.31), LGF: 34.52 (+1.06), OMI: 33.74 (-0.21)
Lannett ups revenue outlook
at Investor's Business Daily - Mon Nov 03, 5:26PM CST
The generic-drug maker's adjusted EPS skyrocketed 327% to 94 cents in Q1 '15, passing views by 10 cents. Revenue soared 104% to $93.4 mil, topping expectations for $91.9 mil. Lannett (LCI) raised its full-year '15 revenue range by $20 mil, to $370...
LCI: 51.48 (+1.31)
Sprint, RetailMeNot Disappoint The Street After Hours
at Investor's Business Daily - Mon Nov 03, 3:57PM CST
Stocks finished mixed Monday, with volume lower across the board. Oil dropped more than $2 a barrel and was trading near $78. After the close, wireless carrier Sprint (S) dropped sharply after announcing disappointing Q4 results. It reported a loss...
LCI: 51.48 (+1.31), S: 4.84 (+0.12), JAZZ: 173.38 (+2.58), SALE: 14.91 (+0.56), KORS: 69.46 (-0.49), PCLN: 1,110.00 (+15.39), BABA: 117.65 (+3.09)
Lannett Reports Net Sales of $93 Million, EPS of $0.94 for Fiscal 2015 First Quarter
Business Wire - Mon Nov 03, 3:05PM CST
Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2015 first quarter ended September 30, 2014.
LCI: 51.48 (+1.31)
Stocks Open Mixed And Quiet; Chipmakers In Motion
at Investor's Business Daily - Mon Nov 03, 9:35AM CST
Stocks wobbled in a mixed start Monday on a cross-current of company news and economic reports. The Nasdaq climbed 0.3% and the Dow Jones industrial average dipped 0.1%, but both moved in soft trade. The S&P 500 added a fraction. Volume was weak on...
AMBA: 48.91 (+1.77), LCI: 51.48 (+1.31), MU: 32.97 (-0.04), SWKS: 61.18 (+1.30), SAPE: 24.65 (-0.02), AFSI: 50.43 (+0.54), CRUS: 19.57 (+0.02), LH: 101.06 (+0.54), CVD: 100.76 (+0.24)
Lannett Announces Positive FDA Inspection Results
Business Wire - Mon Nov 03, 6:54AM CST
Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has completed its cGMP compliance inspection of Lannett's wholly owned subsidiary Cody Laboratories, Inc. (Cody), a manufacturer of active pharmaceutical ingredients (APIs) and finished dosage form products. The inspection commenced on Monday, October 27, 2014, and was completed on Thursday, October 30, 2014.
LCI: 51.48 (+1.31)
Pacira Down on Wider than Expected Q3 Loss, Sales Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 12:00PM CDT
Pacira Pharmaceuticals' (PCRX) third-quarter 2014 loss of 5 cents per share was wider than the Zacks Consensus Estimate of a loss of a penny but much narrower than the year-ago loss of 41 cents per share.
LCI: 51.48 (+1.31), VRX: 127.94 (+1.83), AUXL: 32.72 (-0.03), PCRX: 88.11 (+2.09)
Strength Seen in Cempra (CEMP): Stock Rises 10.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:25AM CDT
Cempra (CEMP) was a big mover last session, with shares rising over 10% on the day.
LCI: 51.48 (+1.31), ADHD: 3.73 (-0.02), CEMP: 13.82 (+0.06), IG: 9.58 (+0.13)
Stocks Add To Gains; Visa, MasterCard Charge Higher
at Investor's Business Daily - Thu Oct 30, 2:06PM CDT
Stocks continued to stretch gains in afternoon trading Thursday after shaking off early weakness. The Dow led major indices, rising 1.3%. The Nasdaq added 0.4% and the S&P 500 climbed 0.7%. Volume was tracking slightly lower across the board in the...
ABC: 87.42 (+0.69), LCI: 51.48 (+1.31), V: 248.65 (-3.78), MA: 84.76 (-0.04)
Insider Trading Alert - EW, SLAB And LCI Traded By Insiders
at The Street - Thu Oct 30, 10:45AM CDT
Stocks with insider trader activity include EW, SLAB and LCI
LCI: 51.48 (+1.31), SLAB: 45.51 (-0.09), EW: 123.51 (+0.75)
Lannett awarded US FDA approval for Letrozole Tablets USP 2.5 mg
M2 - Thu Oct 30, 6:08AM CDT
Generic pharmaceutical company Lannett Company (NYSE:LCI) reported on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Letrozole Tablets USP, 2.5 mg.
LCI: 51.48 (+1.31), NVS: 92.38 (+0.62)
Lannett Receives FDA Approval for Letrozole Tablets USP 2.5 mg
Business Wire - Wed Oct 29, 1:28PM CDT
Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Letrozole Tablets USP, 2.5 mg, the therapeutic equivalent to the reference listed drug, Femara(R) Tablets, 2.5 mg, of Novartis Pharmaceuticals Corporation. According to IMS, for the year ended September 2014 total sales of Letrozole Tablets USP, 2.5 mg, at Average Wholesale Price (AWP) were approximately $359 million. The company expects to commence shipping the product in the coming months.
LCI: 51.48 (+1.31), NVS: 92.38 (+0.62)
United Therapeutics Falls on Q3 Loss, Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 11:02AM CDT
United Therapeutics Corporation (UTHR) incurred a third-quarter loss of 53 cents per share, missing the Zacks Consensus Estimate by a wide margin.
LCI: 51.48 (+1.31), MDT: 68.40 (+0.30), UTHR: 124.75 (+0.54), NVS: 92.38 (+0.62)
Receptos (RCPT) Worth Watching: Stock Moves Up 41.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 8:39AM CDT
Receptos, Inc. (RCPT) was a big mover last session, as its shares rose over 41% on the day.
LCI: 51.48 (+1.31), PTLA: 27.41 (+0.02), RCPT: 109.51 (+0.27), IG: 9.58 (+0.13)
Strength Seen in Zafgen (ZFGN): Stock Adds 7.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 7:51AM CDT
Zafgen, Inc. (ZFGN) was a big mover last session, as its shares rose over 7% on the day.
LCI: 51.48 (+1.31), ZFGN: 19.31 (+0.13), PTLA: 27.41 (+0.02), IG: 9.58 (+0.13)
Lannett to Present at the 2014 Credit-Suisse Healthcare Conference on November 11
Business Wire - Wed Oct 29, 6:54AM CDT
Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the Credit-Suisse 2014 Healthcare Conference on Tuesday, November 11, 2014, at 4:30 p.m. Mountain Standard Time (6:30 p.m. Eastern Standard Time) at The Biltmore Hotel in Phoenix, AZ.
LCI: 51.48 (+1.31)
Recent News posted below.
LCI Lannett Co Inc Recent Headline News
La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:44AM CST
La Jolla Pharmaceutical Co. (LJPC) was a big mover last session, as the company saw its shares surge over 10% on the day
ENDP: 68.87 (-0.09), LCI: 51.48 (+1.31), BCRX: 10.77 (+0.31), LJPC: 13.40 (+1.12)
Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 36.50 (-0.93), LCI: 51.48 (+1.31), AKRX: 35.28 (-1.31), AFSI: 50.43 (+0.54), EXPE: 85.89 (+0.78), FFIV: 126.83 (+0.17), SLXP: 93.62 (+2.15), MPWR: 44.85 (+0.16), TMH: 53.69 (-0.45), ATHM: 44.35 (+0.72)
Let Major Indexes Dictate Buy, Sell Decisions
at Investor's Business Daily - Wed Nov 05, 5:01PM CST
The S&P 500 and Nasdaq composite serve as guideposts to the market's health. Ignore them at your own peril. Every day, IBD analyzes the action of these major stock averages to determine whether the market is in an uptrend (healthy) or a correction...
LCI: 51.48 (+1.31), AKRX: 35.28 (-1.31), ORLY: 179.38 (+0.38), AFSI: 50.43 (+0.54), CELG: 107.62 (+1.17)
Stocks Narrow Losses; Airlines Lead
at Investor's Business Daily - Tue Nov 04, 12:29PM CST
Stocks narrowed losses near midday Tuesday, but some leaders remained under pressure. The Nasdaq fell 0.6%, the S&P 500 dropped 0.4%, and the Dow Jones industrial average was down a fraction. Wal-Mart Stores (WMT), Travelers (TRV) and Procter &...
LCI: 51.48 (+1.31), SAVE: 78.72 (+1.41), WMT: 79.79 (+1.02), PG: 89.11 (-0.02), ATHM: 44.35 (+0.72), TXRH: 31.83 (+0.04), LUV: 38.79 (+0.55), TRV: 102.87 (+0.50)
Insider Trading Alert - LGF, OMI And LCI Traded By Insiders
at The Street - Tue Nov 04, 10:35AM CST
Stocks with insider trader activity include LGF, OMI and LCI
LCI: 51.48 (+1.31), LGF: 34.52 (+1.06), OMI: 33.74 (-0.21)
Lannett ups revenue outlook
at Investor's Business Daily - Mon Nov 03, 5:26PM CST
The generic-drug maker's adjusted EPS skyrocketed 327% to 94 cents in Q1 '15, passing views by 10 cents. Revenue soared 104% to $93.4 mil, topping expectations for $91.9 mil. Lannett (LCI) raised its full-year '15 revenue range by $20 mil, to $370...
LCI: 51.48 (+1.31)
Sprint, RetailMeNot Disappoint The Street After Hours
at Investor's Business Daily - Mon Nov 03, 3:57PM CST
Stocks finished mixed Monday, with volume lower across the board. Oil dropped more than $2 a barrel and was trading near $78. After the close, wireless carrier Sprint (S) dropped sharply after announcing disappointing Q4 results. It reported a loss...
LCI: 51.48 (+1.31), S: 4.84 (+0.12), JAZZ: 173.38 (+2.58), SALE: 14.91 (+0.56), KORS: 69.46 (-0.49), PCLN: 1,110.00 (+15.39), BABA: 117.65 (+3.09)
Lannett Reports Net Sales of $93 Million, EPS of $0.94 for Fiscal 2015 First Quarter
Business Wire - Mon Nov 03, 3:05PM CST
Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2015 first quarter ended September 30, 2014.
LCI: 51.48 (+1.31)
Stocks Open Mixed And Quiet; Chipmakers In Motion
at Investor's Business Daily - Mon Nov 03, 9:35AM CST
Stocks wobbled in a mixed start Monday on a cross-current of company news and economic reports. The Nasdaq climbed 0.3% and the Dow Jones industrial average dipped 0.1%, but both moved in soft trade. The S&P 500 added a fraction. Volume was weak on...
AMBA: 48.91 (+1.77), LCI: 51.48 (+1.31), MU: 32.97 (-0.04), SWKS: 61.18 (+1.30), SAPE: 24.65 (-0.02), AFSI: 50.43 (+0.54), CRUS: 19.57 (+0.02), LH: 101.06 (+0.54), CVD: 100.76 (+0.24)
Lannett Announces Positive FDA Inspection Results
Business Wire - Mon Nov 03, 6:54AM CST
Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has completed its cGMP compliance inspection of Lannett's wholly owned subsidiary Cody Laboratories, Inc. (Cody), a manufacturer of active pharmaceutical ingredients (APIs) and finished dosage form products. The inspection commenced on Monday, October 27, 2014, and was completed on Thursday, October 30, 2014.
LCI: 51.48 (+1.31)
Pacira Down on Wider than Expected Q3 Loss, Sales Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 12:00PM CDT
Pacira Pharmaceuticals' (PCRX) third-quarter 2014 loss of 5 cents per share was wider than the Zacks Consensus Estimate of a loss of a penny but much narrower than the year-ago loss of 41 cents per share.
LCI: 51.48 (+1.31), VRX: 127.94 (+1.83), AUXL: 32.72 (-0.03), PCRX: 88.11 (+2.09)
Strength Seen in Cempra (CEMP): Stock Rises 10.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:25AM CDT
Cempra (CEMP) was a big mover last session, with shares rising over 10% on the day.
LCI: 51.48 (+1.31), ADHD: 3.73 (-0.02), CEMP: 13.82 (+0.06), IG: 9.58 (+0.13)
Stocks Add To Gains; Visa, MasterCard Charge Higher
at Investor's Business Daily - Thu Oct 30, 2:06PM CDT
Stocks continued to stretch gains in afternoon trading Thursday after shaking off early weakness. The Dow led major indices, rising 1.3%. The Nasdaq added 0.4% and the S&P 500 climbed 0.7%. Volume was tracking slightly lower across the board in the...
ABC: 87.42 (+0.69), LCI: 51.48 (+1.31), V: 248.65 (-3.78), MA: 84.76 (-0.04)
Insider Trading Alert - EW, SLAB And LCI Traded By Insiders
at The Street - Thu Oct 30, 10:45AM CDT
Stocks with insider trader activity include EW, SLAB and LCI
LCI: 51.48 (+1.31), SLAB: 45.51 (-0.09), EW: 123.51 (+0.75)
Lannett awarded US FDA approval for Letrozole Tablets USP 2.5 mg
M2 - Thu Oct 30, 6:08AM CDT
Generic pharmaceutical company Lannett Company (NYSE:LCI) reported on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Letrozole Tablets USP, 2.5 mg.
LCI: 51.48 (+1.31), NVS: 92.38 (+0.62)
Lannett Receives FDA Approval for Letrozole Tablets USP 2.5 mg
Business Wire - Wed Oct 29, 1:28PM CDT
Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Letrozole Tablets USP, 2.5 mg, the therapeutic equivalent to the reference listed drug, Femara(R) Tablets, 2.5 mg, of Novartis Pharmaceuticals Corporation. According to IMS, for the year ended September 2014 total sales of Letrozole Tablets USP, 2.5 mg, at Average Wholesale Price (AWP) were approximately $359 million. The company expects to commence shipping the product in the coming months.
LCI: 51.48 (+1.31), NVS: 92.38 (+0.62)
United Therapeutics Falls on Q3 Loss, Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 11:02AM CDT
United Therapeutics Corporation (UTHR) incurred a third-quarter loss of 53 cents per share, missing the Zacks Consensus Estimate by a wide margin.
LCI: 51.48 (+1.31), MDT: 68.40 (+0.30), UTHR: 124.75 (+0.54), NVS: 92.38 (+0.62)
Receptos (RCPT) Worth Watching: Stock Moves Up 41.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 8:39AM CDT
Receptos, Inc. (RCPT) was a big mover last session, as its shares rose over 41% on the day.
LCI: 51.48 (+1.31), PTLA: 27.41 (+0.02), RCPT: 109.51 (+0.27), IG: 9.58 (+0.13)
Strength Seen in Zafgen (ZFGN): Stock Adds 7.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 7:51AM CDT
Zafgen, Inc. (ZFGN) was a big mover last session, as its shares rose over 7% on the day.
LCI: 51.48 (+1.31), ZFGN: 19.31 (+0.13), PTLA: 27.41 (+0.02), IG: 9.58 (+0.13)
Lannett to Present at the 2014 Credit-Suisse Healthcare Conference on November 11
Business Wire - Wed Oct 29, 6:54AM CDT
Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the Credit-Suisse 2014 Healthcare Conference on Tuesday, November 11, 2014, at 4:30 p.m. Mountain Standard Time (6:30 p.m. Eastern Standard Time) at The Biltmore Hotel in Phoenix, AZ.
LCI: 51.48 (+1.31)
